Schneider Eugene's Form 4 filing
Ionis Pharmaceuticals Inc (IONS) · filed Jan 17, 2024
- Accession no.
- 0000874015-24-000059
- Filed
- Jan 17, 2024
- Trade date
- Jan 12-15, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market sales total $428.0K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schneider EugeneCIK 0001838539 | Officer (EVP, Chf Clinical Develop Ofcr) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | Common Stock | MOption exerciseAcquired | +8,000 | $32.60 | +$260,800 | 46,170 | Direct | |
| Jan 12, 2024 | Common Stock | SSaleDisposed | −8,000 | $53.50 | −$428,000 | 38,170 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | Common Stock | MOption exerciseDisposed | −8,000 | $0.00 | $0 | 24,265 | Direct | |
| Jan 15, 2024 | Common Stock | AGrant or awardAcquired | +17,000 | $0.00 | $0 | 43,437 | Direct | |
| Jan 15, 2024 | Common Stock | AGrant or awardAcquired | +20,400 | $0.00 | $0 | 60,470 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.